CARLSMED, INC.CARLEarnings & Financial Report
Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus
CARL Q1 FY2026 Key Financial Metrics
Revenue
$16.1M
Gross Profit
$12.4M
Operating Profit
$-5.6M
Net Profit
$51.8K
Gross Margin
77.1%
Operating Margin
-34.7%
Net Margin
0.3%
YoY Growth
58.2%
CARLSMED, INC. Q1 FY2026 Financial Summary
CARLSMED, INC. reported revenue of $16.1M (up 58.2% YoY) for Q1 FY2026, with a net profit of $51.8K (0.3% margin). Cost of goods sold was $3.7M, operating expenses totaled $18.0M.
Key Financial Metrics
| Total Revenue | $16.1M |
|---|---|
| Net Profit | $51.8K |
| Gross Margin | 77.1% |
| Operating Margin | -34.7% |
| Report Period | Q1 FY2026 |
CARLSMED, INC. Quarterly Revenue & Net Profit History
CARLSMED, INC. results over the last 4 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $16.1M | +58.2% | $51.8K | 0.3% |
| Q4 FY2025 | $15.2M | +61.2% | $82.5K | 0.5% |
| Q3 FY2025 | $13.1M | — | $-8.5M | -65.2% |
| Q2 FY2025 | $12.1M | — | $-6.8M | -56.0% |
Income Statement
| Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|
| Revenue | $12.1M | $13.1M | $15.2M | $16.1M |
| YoY Growth | N/A | N/A | 61.2% | 58.2% |
Balance Sheet
| Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|
| Assets | $53.3M | $134.9M | $130.1M | $118.8M |
| Liabilities | $27.6M | $28.2M | $31.3M | $26.5M |
| Equity | $-83.1M | $106.7M | N/A | N/A |
Cash Flow
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Operating CF | $-15.2M | $-8.5M |